Carbamazepine dosages

For example carbamazepine is both a substrate and an inducer of 3A4. Thus as treatment becomes chronic, 3A4 is induced and carbamazepine blood levels fall (Fig. 6—19)- Failure to recognize this effect and to increase carbamazepine dosage to compensate for it may lead to a failure of anticonvulsant or mood-stabilizing efficacy, with breakthrough symptoms. 

A 23-year-old man had raised 9-hydroxyrisperidone concentrations in association with carbamazepine dosage reduction and concomitant fluvoxamine therapy (244). 

Negative myoclonus and more typical signs of carbamazepine intoxication (fatigue, ataxia, clumsiness) occurred in a 66-year-old man after he took add-on clobazam (10 mg/day) for 4 weeks (14). Plasma concentrations of carbamazepine (58 pmol/1) and carbamazepine-10,11-epoxide (19 pmol/1) were higher than before clobazam therapy, and his symptoms resolved quickly when carbamazepine dosage was reduced and clobazam was withdrawn. The interaction was confirmed on rechallenge. 

Monitor hepatic function closely while using this combination Monitor toxicity of carbamazepine dosage may require reduction... 

The elderly appear to be at increased risk of blood dys-crasias and liver reactions (39). Age above 55 years was associated with a greater risk of toxicity after rapid switch-over to a carbamazepine dosage designed to jdeld a plasma concentration of 10 pg/ml (76). Moderately severe to severe adverse effects in the 11 patients in either subgroup included sedation, ataxia, and confusion. 

Discuss the problems with the administration of demeclocycline post-carbamazepine dosage. 

The seizure control of 54 children with grand mal and temporal lobe epilepsy was improved when acetazolamide 10 mg/kg daily was added to carbamazepine. Serum carbamazepine levels rose by 1 to 6 mg/L in 60% of the 33 patients sampled. Adverse effects developed in 10 children, and in 8 children this was within 1 to 10 days of starting the acetazolamide. The adverse effects responded to a reduction in the carbamazepine dosage. ... 

Information about the effects of calcium-channel bloekers on ear-bamazepine is limited, but what is known indicates that if carbamazepine is given with verapamil or diltiazem, the carbamazepine dosage may possibly need to be reduced to avoid toxicity. A 50% reduction in the dose of carbamazepine has been suggested if diltiazem is to be used. Nifedipine and amlodipine normally appear to be non-interaeting alternatives. Oxear-bazepine appears to be a non-interaeting alternative for carbamazepine. 

The interaction between carbamazepine and clarithromycin is also established, clinically important and potentially serious. However, the extent of the interaction is less with clarithromycin than with erythromycin or troleandomycin (i.e. the rise in carbamazepine levels is less)." It has been recommended that carbamazepine dosages should be reduced by 30 to 50% during treatment with clarithromycin, with monitoring within 3 to 5 days, and patients should be told to tell their doctor of any symptoms of toxicity (dizziness, diplopia, ataxia, mental confusion). 

Two patients developed carbamazepine toxicity (diplopia, blurred vision, tremor, vertigo, nausea, tinnitus etc.) within 7 and 10 days of starting to take fluoxetine 20 mg daily. Their serum carbamazepine levels were found to have risen by about 33% and 60%, respectively. The problem was resolved in one of them by reducing the carbamazepine dosage from 1 g to 800 mg daily, and in the other by stopping the fluoxetine. The effects seen in these cases are supported by a study in 6 healthy patients, where adding fluoxetine 20 mg daily to steady-state carbamazepine caused a rise in the AUC of carbamazepine and carbamazepine-10,11-epoxide (its active metabolite) of about 25 to 50%. ... 

Information is limited but the interaction appears to be established. Patients taking earbamazepine who also take valnoctamide could rapidly develop carbamazepine toxicity because the metabolism of its major metabolite, carbamazepine-10,11-epoxide, is inhibited. This interaction is very similar to the interaction that occurs between carbamazepine and val-promide (an isomer of valnoctamide), see Carbamazepine + Valproate , below. Concurrent valnoctamide should be avoided unless the carbamazepine dosage can be reduced appropriately. 

Sevketoglu E, Hatipoglu S, Akman M, Bicer S. Toxic epidermal necrolysis in a child after carbamazepine dosage increment. Pediatr Emerg Care 2009 25(2) 93-5. 

---